Literature DB >> 12183521

Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.

Giorgio Santoni1, Maria Boccanera, Daniela Adriani, Roberta Lucciarini, Consuelo Amantini, Stefania Morrone, Antonio Cassone, Flavia De Bernardis.   

Abstract

The protective roles of different lymphocyte subsets were investigated in a rat vaginal candidiasis model by adoptive transfer of vaginal lymphocytes (VL) or sorted, purified CD3(+) T cells, CD4(+) or CD8(+) T cells, or CD3(-) CD5(+) B cells from the vaginas of naïve or immune rats following three rounds of Candida albicans infection. The adoptive transfer of total VL from nonimmune animals did not alter the course of vaginal candidiasis of the recipient rats. In contrast, the animals receiving total VL or CD3(+) T cells from immune rats showed a highly significant acceleration of fungus clearance compared with animals which received nonimmune VL. The animals with vaginal CD3(-) CD5(+) B cells transferred from immune rats also had fewer Candida CFU than the controls, but fungal clearance was significantly retarded with respect to the animals administered immune T cells. Sorted, purified CD4(+) and CD8(+) vaginal T cells from immune rats were also adoptively transferred to naïve animals. Although both populations were seen to accelerate the clearance of the fungus from the vagina, CD4(+) T cells were much more effective than CD8(+) T cells. Overall, there was no difference between the antifungal effects of immune vaginal CD4(+) T cells and those achievable with the transfer of whole, immune VL. Histological observations of the vaginal tissues of rats with adoptively transferred immune T cells demonstrated a remarkable accumulation of lymphocytes in the subepithelial lamina propria and also infiltrating the mucosal epithelium. These results strongly suggest that distinct vaginal lymphocyte subsets participate in the adaptive anti-Candida immunity at the vaginal level, with the vaginal CD4(+) T cells probably playing a major role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183521      PMCID: PMC128254          DOI: 10.1128/IAI.70.9.4791-4797.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.

Authors:  R D Mulero-Marchese; K J Blank; T G Sieck
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

2.  Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization.

Authors:  R D Mulero-Marchese; K J Blank; T G Sieck
Journal:  Immunogenetics       Date:  1999-10       Impact factor: 2.846

3.  High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women.

Authors:  F de Bernardis; F Mondello; G Scaravelli; A Pachì; A Girolamo; L Agatensi; A Cassone
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Local production of chemokines during experimental vaginal candidiasis.

Authors:  M Saavedra; B Taylor; N Lukacs; P L Fidel
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Analysis of vaginal cell populations during experimental vaginal candidiasis.

Authors:  P L Fidel; W Luo; C Steele; J Chabain; M Baker; F Wormley
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes.

Authors:  C A Black; F M Eyers; A Russell; M L Dunkley; R L Clancy; K W Beagley
Journal:  J Reprod Immunol       Date:  1999-11       Impact factor: 4.054

7.  Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.

Authors:  F de Bernardis; G Santoni; M Boccanera; E Spreghini; D Adriani; L Morelli; A Cassone
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 8.  Innate and adaptive immunity in Candida albicans infections and saprophytism.

Authors:  L Romani
Journal:  J Leukoc Biol       Date:  2000-08       Impact factor: 4.962

9.  Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.

Authors:  J E Leigh; M Barousse; R K Swoboda; T Myers; S Hager; N A Wolf; J L Cutright; J Thompson; J D Sobel; P L Fidel
Journal:  J Infect Dis       Date:  2000-12-13       Impact factor: 5.226

10.  Human vaginal mucosal immune system: characterization and function.

Authors:  Y Elitsur; S Jackman; C Neace; S Keerthy; X Liu; J Dosescu; J A Moshier
Journal:  Gen Diagn Pathol       Date:  1998-04
View more
  12 in total

1.  Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.

Authors:  Flavia De Bernardis; Roberta Lucciarini; Maria Boccanera; Consuelo Amantini; Silvia Arancia; Stefania Morrone; Michela Mosca; Antonio Cassone; Giorgio Santoni
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 3.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

4.  Prospects for development of a vaccine to prevent and control vaginal candidiasis.

Authors:  Paul L Fidel; Jim E Cutler
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

5.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

6.  Vaginal T lymphocyte population kinetics during experimental vaginal candidosis: evidence for a possible role of CD8+ T cells in protection against vaginal candidosis.

Authors:  M Ghaleb; M Hamad; K H Abu-Elteen
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 7.  Experimental Models of Vaginal Candidiasis and Their Relevance to Human Candidiasis.

Authors:  Antonio Cassone; Jack D Sobel
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

8.  Immune Regulation and Its Role in the Pathogenesis of Candida Vaginitis.

Authors:  Paul L. Fidel
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 9.  Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".

Authors:  Junko Yano; Brian M Peters; Mairi C Noverr; Paul L Fidel
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 10.  Arachidonic acid metabolites in pathogenic yeasts.

Authors:  Ruan Ells; Johan Lf Kock; Jacobus Albertyn; Carolina H Pohl
Journal:  Lipids Health Dis       Date:  2012-08-08       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.